Navigation Links
UT rheumatologists discover 2 genes related to disabling form of arthritis
Date:10/21/2007

HOUSTON (Oct. 22, 2007)Work done in part by researchers at The University of Texas Medical School at Houston has led to the discovery of two genes that cause ankylosing spondylitis, an inflammatory and potentially disabling disease. The findings are published in the Oct. 21 online edition of Nature Genetics, a journal that emphasizes research on the genetic basis for common and complex diseases.

John D. Reveille, M.D., professor and director of the Division of Rheumatology and Clinical Immunogenetics, in conjunction with Matthew A. Brown, M.D., professor of immunogenetics at Australias University of Queensland, led research done by the Triple A Spondylitis Consortium Genetic Study (i.e. the TASC or Australo-Anglo-American Spondylitis Consortium).

The international team of researchers worked with investigators from the British Wellcome Trust Case Control Consortium, and together they made the genetic discovery.

Reveille, chief of rheumatology at Memorial Hermann Texas Medical Center, said the discovery of genes ARTS1 and IL23R brings the scientific community two steps closer to fully understanding ankylosing spondylitis or AS, a chronic form of arthritis that attacks the spine and also can target other joints and organs in the body.

Weve long known that the HLA-B27 gene accounts for 40 percent of the overall cause of AS, said Reveille, the principal investigator of TASC. Now we have found two new genes. Together with HLA-B27, these genes account for roughly 70 percent of the overall cause. That means weve almost nailed this disease. Within the next year, I predict we will have identified all the genes that play a role in this insidious disease. There is more exciting news to come.

The recent discovery is based on work from the largest and most comprehensive genome-wide association scan conducted to date. In this part of the research project, investigators were searching for genetic information related to AS, as well as autoimmune thyroid disease/Graves Disease, breast cancer and multiple sclerosis. Reveille, the George S. Bruce, Jr. Professor in Arthritis and Other Rheumatic Diseases, said the most significant findings were in AS, a disease that generally strikes patients in their teens, 20s or 30s.

ARTS1 and IL23R show a new pathway of causation, Reveille said, and this could lead to new therapies for the arthritic condition, which can cause a complete fusion of the spine, leaving patients unable to straighten and bend.

The identification of the two new genes also could help physicians identify patients who are at the highest risk for developing AS.

For example, if you have a family member with AS, a simple blood test would be able to tell us if you are also at risk, Reveille said. We could offer screenings for people with back pain. In the past, the HLA-B27 test was all we had. Now we potentially have more tests.

Steve Haskew, who has lived with AS for thirty years, said the genetic discovery offers hope to patients especially those who are newly diagnosed.

When I first started experiencing problems lower back pain, the aching joints no one could tell me what was wrong, said Haskew, 59, co-leader of an AS support group that meets every other month at the UT Medical School at Houston. It took 10 years before a rheumatologist diagnosed me with AS. Back then, there werent many options. I was told to take anti-inflammatories and stay as active as possible. Its fascinating to see how far weve come and how much has been learned about the disease since then.

The research done by Reveille and his colleague Xiaodong Zhou, M.D., associate professor of medicine in Division of Rheumatology and Clinical Immunogenetics, was supported in part by the Center for Clinical and Translational Sciences (CCTS) at The University of Texas Health Science Center at Houston.

This is a success story for genetics work, and I think it will lead the way for other work to be done, Reveille said.

The Spondylitis Association of America (SAA) oversaw the nationwide recruitment of patients and families for the study.

This is the most significant breakthrough in AS genetic research since HLA-B27 was uncovered 34 years ago, and SAA played a significant role in making the study possible, said SAA Associate Executive Director Laurie Savage, who is co-principal investigator for TASCs administrative core.


'/>"/>

Contact: Meredith Raine
Meredith.Raine@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert

Related medicine news :

1. Rheumatologists Underestimate the Patients Ability to Work
2. PRIMARY PULMONARY HYPERTENSION GENE DISCOVERED
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. OHSU Researchers Announce New Discovery
5. Poisonous Parkinsons molecule discovered
6. Discovery of bone gene
7. Genes for Vision discovered
8. Chemists Discover Cation Considered Too Unstable To Exist
9. New breast cancer genes discovered
10. Latest discovery on Autism
11. Bacterial discovery may help CF patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release ... show in Cannes (France), XO Private has initiated a second print-run of its lavish ... almost a metre across when open, weighs in at more than six kilos, retails ...
(Date:2/24/2017)... ... ... An in-depth computational analysis of genetic variants implicated in both schizophrenia and rheumatoid ... explain why susceptibility to one of the disorders could place individuals at lower risk ... journal npj Schizophrenia. , “There is a wealth of genomic data on both ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could it ... the United States may be taken over by technology in the next five to ... over colleagues is drawing to a close. Success will belong to those who can ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Period October – December 2016 Revenues amounted ... -16.4 (-6.4) million Result after tax amounted to SEK -16.3 ... Cash flow from operating activities amounted to SEK -8.3 (-7.3) ... Period full year 2016 ... Operating result amounted to SEK -39.5 (-29.5) million Result ...
(Date:2/24/2017)... YORK , February 24, 2017 Following ... Israel , s AMAR ... $ 250 M w ound care market ... s BST for inclusion in the ... healthcare reimbursement system   E-QURE Corp. (OTCQB: ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of the ... 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow at ... $2.9 billion by 2025. This industry report analyzes the ... well as regional levels presented in the research scope. The study provides ...
Breaking Medicine Technology: